Literature DB >> 17827063

Modulators of neuronal cell death in epilepsy.

David C Henshall1, Brona M Murphy.   

Abstract

Experimental and human data have shown that certain seizures cause damage to brain. Such neuronal loss may result in cognitive impairments and perhaps contribute to the development or phenotype of emergent epilepsy. Recent work using genetically modified mice, Tat protein transduction, and viral vectors has shown functional effects of manipulating Bcl-2 and Bcl-w, heat shock proteins, caspases, and their regulators and endonucleases on neuronal death in models of status epilepticus. Ancillary effects on seizure induction and excitability thresholds have emerged for several genes suggesting additional properties of therapeutic potential. Differing hippocampal expression of certain Bcl-2 family genes, elevated endoplasmic reticulum stress chaperones, and death receptor pathway modulation in epilepsy patients support clinical relevance of this focus. These findings may yield potentially valuable adjunctive neuroprotective or anti-epileptogenic strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827063     DOI: 10.1016/j.coph.2007.07.005

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  22 in total

1.  Interictal spikes in developing rats cause long-standing cognitive deficits.

Authors:  Omar I Khan; Qian Zhao; Forrest Miller; Gregory L Holmes
Journal:  Neurobiol Dis       Date:  2010-05-07       Impact factor: 5.996

2.  Role of endoplasmic reticulum stress via the PERK signaling pathway in brain injury from status epilepticus.

Authors:  Jing Chen; Guo Zheng; Hu Guo; Zhong-Nan Shi
Journal:  J Mol Neurosci       Date:  2014-01-23       Impact factor: 3.444

3.  BACE1 deficiency causes altered neuronal activity and neurodegeneration.

Authors:  Xiangyou Hu; Xiangdong Zhou; Wanxia He; Jun Yang; Wencheng Xiong; Philip Wong; Christopher G Wilson; Riqiang Yan
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

4.  Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy.

Authors:  Alberto E Musto; Mark Samii
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

5.  Deletion of Puma protects hippocampal neurons in a model of severe status epilepticus.

Authors:  T Engel; S Hatazaki; K Tanaka; J H M Prehn; D C Henshall
Journal:  Neuroscience       Date:  2010-04-01       Impact factor: 3.590

6.  Reactive oxygen species mediate cognitive deficits in experimental temporal lobe epilepsy.

Authors:  Jennifer N Pearson; Shane Rowley; Li-Ping Liang; Andrew M White; Brian J Day; Manisha Patel
Journal:  Neurobiol Dis       Date:  2015-07-13       Impact factor: 5.996

7.  Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

Authors:  Alberto Pauletti; Gaetano Terrone; Tawfeeq Shekh-Ahmad; Alessia Salamone; Teresa Ravizza; Massimo Rizzi; Anna Pastore; Rosaria Pascente; Li-Ping Liang; Bianca R Villa; Silvia Balosso; Andrey Y Abramov; Erwin A van Vliet; Ennio Del Giudice; Eleonora Aronica; Manisha Patel; Matthew C Walker; Annamaria Vezzani
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

8.  Control of postnatal apoptosis in the neocortex by RhoA-subfamily GTPases determines neuronal density.

Authors:  Hitomi Sanno; Xiao Shen; Nilgün Kuru; Ingo Bormuth; Kristin Bobsin; Humphrey A R Gardner; Dorde Komljenovic; Victor Tarabykin; Reha S Erzurumlu; Kerry L Tucker
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

Review 9.  Frontier of epilepsy research - mTOR signaling pathway.

Authors:  Chang Hoon Cho
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

10.  The effect of metformin treatment on endoplasmic reticulum (ER) stress induced by status epilepticus (SE) via the PERK-eIF2α-CHOP pathway.

Authors:  Jing Chen; Guo Zheng; Hu Guo; Zhong-Nan Shi; Jiao Jiang; Xiao-Yu Wang; Xiao Yang; Xian-Yu Liu
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.